India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study......
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its COVID vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the......
United Kingdom-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of......
'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters The controversial......
In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......
Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as “absolutely baseless”, saying India......
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive, reports Sohini Das/Business Standard. IMAGE: A beneficiary......
'We speak with the players every day to say be careful. Stay healthy, wear masks, social distance.' IMAGE: Pep Guardiola said Leeds, who are 12 points behind City in the English Premier......